Nchi: Uswisi
Lugha: Kiitaliano
Chanzo: Swissmedic (Swiss Agency for Therapeutic Products)
haemagglutininum influenzae di tipo A (H1N1), neuraminidasum inactivatum (Virus-Stamm A/California/7/2009 X-181)
Emergent BioSolutions Berna GmbH
J07BB02
haemagglutininum influenzae A (H1N1), neuraminidasum inactivatum (Virus-Stamm A/California/7/2009 X-181)
Siringa preriempita
haemagglutininum influenzae di tipo A (H1N1) e neuraminidasum inactivatum (Virus-Stamm A/California/7/2009 X-181) 7.5 µg, adjuvans MF59: squalenum, polysorbatum 80, sorbitani trioleas, natrii citras dihydricus, acido citricum monohydricum, excipiens: natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesio chloridum hexahydricum, calcio chloridum dihydricum, acqua q.s. la sospensione 0,5 ml.
B
Vaccini
Vaccino Influenzale Pandemico
2009-10-27